Act Two Investors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-35,357
Closed -$17.9M 47
2024
Q4
$17.9M Sell
35,357
-29,319
-45% -$16.7M 3.48% 12
2024
Q3
$37.8M Sell
64,676
-1,022
-2% -$578K 7.13% 4
2024
Q2
$33.5M Buy
65,698
+4,420
+7% +$2.17M 6.62% 6
2024
Q1
$30.3M Buy
61,278
+4,510
+8% +$2.29M 6.09% 6
2023
Q4
$29.9M Buy
56,768
+2,609
+5% +$1.39M 6.46% 5
2023
Q3
$27.3M Buy
54,159
+6,639
+14% +$3.27M 7.31% 4
2023
Q2
$22.8M Buy
47,520
+11,966
+34% +$5.85M 6.39% 6
2023
Q1
$16.8M Buy
35,554
+30,830
+653% +$14.9M 6.7% 6
2022
Q4
$2.5M Sell
4,724
-4
-0.1% -$2.12K 2.59% 14
2022
Q3
$2.39M Sell
4,728
-573
-11% -$301K 2.42% 14
2022
Q2
$2.72M Sell
5,301
-123
-2% -$61.8K 2.57% 13
2022
Q1
$2.71M Buy
5,424
+627
+13% +$302K 2.15% 15
2021
Q4
$2.41M Sell
4,797
-57,285
-92% -$25.9M 1.9% 15
2021
Q3
$24.3M Sell
62,082
-15,304
-20% -$6.34M 5.76% 6
2021
Q2
$31M Buy
+77,386
New +$30.9M 6.06% 9

Other funds holding UNH

Act Two Investors's UNH Position: Q1 2025 in Review

Act Two Investors sold out of UnitedHealth (UNH) in Q1 2025, closing a stake of 35,357 shares — an estimated $17.9M sold.

Act Two Investors first reported a position in UNH in Q2 2021 and held it in 15 quarters. The position peaked at $37.8M in Q3 2024. 3,603 funds tracked by Wall St. Rank hold UNH as of Q1 2025.

  • Act Two Investors reported no remaining UnitedHealth position as of Q1 2025 after selling out during the quarter.
  • Act Two Investors sold 35,357 UnitedHealth shares in Q1 2025, an estimated $17.9M.
  • Act Two Investors first reported a position in UnitedHealth in Q2 2021 and held it in 15 quarters.
  • Act Two Investors's UnitedHealth position peaked at $37.8M in Q3 2024.
  • 3,603 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2025.

Based on Act Two Investors's 13F filing for Q1 2025, filed 12 May 2025.